The MASCC/ISOO Mucositis Guidelines: Dissemination and Clinical Impact

Overview

Journal Support Care Cancer

Specialties Critical Care
Oncology

Date 2013 Aug 15

PMID 23942597

Citations 14

Authors

Rajesh V Lalla

Fredrick D Ashbury

Affiliations

Soon will be listed here.

Citing Articles

A randomized, controlled trial to investigate cognitive behavioral therapy in prevention and treatment of acute oral mucositis in patients with locoregional advanced nasopharyngeal carcinoma undergoing chemoradiotherapy.

He L, Xiao S, Jiang C, Wu X, Liu W, Fan C Front Oncol. 2023; 13:1143401.

PMID: 37350940 PMC: 10282775. DOI: 10.3389/fonc.2023.1143401.

A prospective randomized study comparing the efficacy between povidone-iodine gargling and benzydamine hydrochloride for mucositis prevention in head and neck cancer patients receiving concurrent chemoradiotherapy.

Kannarunimit D, Chotirut A, Prayongrat A, Pakvisal N, Sitthideatphaiboon P, Lertbutsayanukul C Heliyon. 2023; 9(4):e15437.

PMID: 37151677 PMC: 10161604. DOI: 10.1016/j.heliyon.2023.e15437.

Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy.

Yang D, Wang X, Zhou X, Zhao J, Yang H, Wang S Oncoimmunology. 2021; 10(1):1976953.

PMID: 34595059 PMC: 8477924. DOI: 10.1080/2162402X.2021.1976953.

Breakdown of Symbiosis in Radiation-Induced Oral Mucositis.

Ingrosso G, Saldi S, Marani S, Wong A, Bertelli M, Aristei C J Fungi (Basel). 2021; 7(4).

PMID: 33921294 PMC: 8068946. DOI: 10.3390/jof7040290.

The Effects of Early Nutritional Intervention on Oral Mucositis and Nutritional Status of Patients With Head and Neck Cancer Treated With Radiotherapy.

Zheng Z, Zhao X, Zhao Q, Zhang Y, Liu S, Liu Z Front Oncol. 2021; 10:595632.

PMID: 33598427 PMC: 7882690. DOI: 10.3389/fonc.2020.595632.

References

Nicolatou-Galitis O, Sarri T, Bowen J, Palma M, Kouloulias V, Niscola P . Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer. 2012; 21(1):357-64. DOI: 10.1007/s00520-012-1613-6. View

Lalla R . The MASCC/ISOO Mucositis Guidelines Update: introduction to the first set of articles. Support Care Cancer. 2012; 21(1):301-2. DOI: 10.1007/s00520-012-1660-z. View

Raber-Durlacher J, von Bultzingslowen I, Logan R, Bowen J, Al-Azri A, Everaus H . Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer. 2012; 21(1):343-55. DOI: 10.1007/s00520-012-1594-5. View

Boaz A, Baeza J, Fraser A . Effective implementation of research into practice: an overview of systematic reviews of the health literature. BMC Res Notes. 2011; 4:212. PMC: 3148986. DOI: 10.1186/1756-0500-4-212. View

Elad S, Bowen J, Zadik Y, Lalla R . Development of the MASCC/ISOO Clinical Practice Guidelines for Mucositis: considerations underlying the process. Support Care Cancer. 2012; 21(1):309-12. DOI: 10.1007/s00520-012-1593-6. View

Boers-Doets C, Epstein J, Raber-Durlacher J, Ouwerkerk J, Logan R, Brakenhoff J . Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature review. Oncologist. 2011; 17(1):135-44. PMC: 3267813. DOI: 10.1634/theoncologist.2011-0111. View

Bowen J, Elad S, Hutchins R, Lalla R . Methodology for the MASCC/ISOO Mucositis Clinical Practice Guidelines Update. Support Care Cancer. 2012; 21(1):303-8. DOI: 10.1007/s00520-012-1592-7. View

Gibson R, Keefe D, Lalla R, Bateman E, Blijlevens N, Fijlstra M . Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer. 2012; 21(1):313-26. DOI: 10.1007/s00520-012-1644-z. View

Gagliardi A . Translating knowledge to practice: optimizing the use of guidelines. Epidemiol Psychiatr Sci. 2012; 21(3):231-6. DOI: 10.1017/S2045796012000212. View

10.

Peterson D, Bensadoun R, Roila F . Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol. 2010; 21 Suppl 5:v261-5. DOI: 10.1093/annonc/mdq197. View

11.

Peterson D, Bensadoun R, Lalla R, McGuire D . Supportive care treatment guidelines: value, limitations, and opportunities. Semin Oncol. 2011; 38(3):367-73. PMC: 4835803. DOI: 10.1053/j.seminoncol.2011.03.005. View

12.

Grimshaw J, Schunemann H, Burgers J, Cruz A, Heffner J, Metersky M . Disseminating and implementing guidelines: article 13 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc. 2012; 9(5):298-303. DOI: 10.1513/pats.201208-066ST. View

13.

Peterson D, Ohrn K, Bowen J, Fliedner M, Lees J, Loprinzi C . Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Support Care Cancer. 2012; 21(1):327-32. DOI: 10.1007/s00520-012-1562-0. View

14.

Migliorati C, Hewson I, Lalla R, Spindola Antunes H, Estilo C, Hodgson B . Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer. 2012; 21(1):333-41. DOI: 10.1007/s00520-012-1605-6. View

15.

Bensinger W, Schubert M, Ang K, Brizel D, Brown E, Eilers J . NCCN Task Force Report. prevention and management of mucositis in cancer care. J Natl Compr Canc Netw. 2008; 6 Suppl 1:S1-21. View

16.

Harris D, Eilers J, Harriman A, Cashavelly B, Maxwell C . Putting evidence into practice: evidence-based interventions for the management of oral mucositis. Clin J Oncol Nurs. 2008; 12(1):141-52. DOI: 10.1188/08.CJON.141-152. View